Literature DB >> 15186955

Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers.

Ramon Estruch1, Emilio Sacanella, Eva Badia, Emilia Antúnez, José Maria Nicolás, Joaquim Fernández-Solá, Domenico Rotilio, Giovanni de Gaetano, Emanuel Rubin, Alvaro Urbano-Márquez.   

Abstract

BACKGROUND: No intervention studies have explored the anti-inflammatory effects of different alcoholic beverages on markers of atherosclerosis. We embarked on a randomized, crossover, single-blinded trial to evaluate the effects of wine and gin on inflammatory biomarkers of atherosclerosis. METHODS AND
RESULTS: Forty healthy men (mean age, 37.6 years) consumed 30 g ethanol per day as either wine or gin for 28 days. Before and after each intervention, we measured the expression of lymphocyte function-associated antigen 1 (LFA-1), Mac-1, very late activation antigen 4 (VLA-4), and monocyte chemoattractant protein (MCP-1) in monocytes, as well as the soluble vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), interleukin-1alpha (IL-1alpha), C-reactive protein (hs-CRP) and fibrinogen. After either gin or wine consumption, plasma fibrinogen decreased by 5 and 9%, respectively, and cytokine IL-1alpha by 23 and 21%. The expression of LFA-1 (-27%), Mac-1 (-27%), VLA-4 (-32%) and MCP-1 (-46%) decreased significantly after wine, but not after gin. Wine reduced the serum concentrations of hs-CRP (-21%), VCAM-1 (-17%) and ICAM-1 (-9%).
CONCLUSIONS: Both wine and gin showed anti-inflammatory effects by reducing plasma fibrinogen and IL-1alpha levels. However, wine had the additional effect of decreasing hs-CRP, as well as monocyte and endothelial adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186955     DOI: 10.1016/j.atherosclerosis.2004.03.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  46 in total

1.  Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis.

Authors:  Simona Costanzo; Augusto Di Castelnuovo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano
Journal:  Eur J Epidemiol       Date:  2011-11-11       Impact factor: 8.082

2.  Alcohol, wine and cardiovascular disease, two sides of the same coin.

Authors:  Ramon Estruch; Rosa Maria Lamuela-Raventós
Journal:  Intern Emerg Med       Date:  2010-07-02       Impact factor: 3.397

3.  Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression.

Authors:  Nadia Calabriso; Egeria Scoditti; Marika Massaro; Mariangela Pellegrino; Carlo Storelli; Ilaria Ingrosso; Giovanna Giovinazzo; Maria Annunziata Carluccio
Journal:  Eur J Nutr       Date:  2015-02-28       Impact factor: 5.614

4.  Dietary pattern, inflammation, and incidence of type 2 diabetes in women.

Authors:  Matthias B Schulze; Kurt Hoffmann; JoAnn E Manson; Walter C Willett; James B Meigs; Cornelia Weikert; Christin Heidemann; Graham A Colditz; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

Review 5.  Grapes and cardiovascular disease.

Authors:  Mustali M Dohadwala; Joseph A Vita
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

6.  Alcohol consumption and atherosclerotic burden in the proximal thoracic aorta.

Authors:  Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Atherosclerosis       Date:  2011-08-16       Impact factor: 5.162

Review 7.  Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms.

Authors:  Augusto Di Castelnuovo; Simona Costanzo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2010-02-03       Impact factor: 3.397

8.  Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.

Authors:  Divya Kapoor; Dimple Trikha; Rajesh Vijayvergiya; K K Parashar; Deepak Kaul; Veena Dhawan
Journal:  J Cardiovasc Transl Res       Date:  2015-04-01       Impact factor: 4.132

9.  Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites.

Authors:  Maria Hidalgo; Sonsoles Martin-Santamaria; Isidra Recio; Concepcion Sanchez-Moreno; Beatriz de Pascual-Teresa; Gerald Rimbach; Sonia de Pascual-Teresa
Journal:  Genes Nutr       Date:  2012-01-05       Impact factor: 5.523

10.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.